BeStock  

Waters WAT

US equityMarket cap rank #483Diagnostics & Research
$440.45 −$16.03 (-3.51%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $440.45 0.00%
Open$454.35
Prev close$456.48
Day range$437.54 – $455.14
Volume1.35M
Market cap$43.29B
P/E (TTM)184.3
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Oct 2026

Revenue$1.77B+120.9% YoY
Operating profit$140.00M-27.1% YoY
Net profit$81.00M-45.6% YoY
Diluted EPS$0.82-67.2% YoY
Free cash flow$54.00M-66.7% YoY
Operating cash flow$117.00M

Revenue, last 8 quarters

$872.7MDec '24$662.0MMar '25$771.0MJun '25$800.0MSep '25$932.3MDec '25$1.3BApr '26$1.6BJul '26$1.8BOct '26

Net profit, last 8 quarters

$231.4MDec '24$121.0MMar '25$147.0MJun '25$149.0MSep '25$224.6MDec '25$-72.0MApr '26$-136.0MJul '26$81.0MOct '26

Diluted EPS by quarter

3.88Dec '242.03Mar '252.47Jun '252.50Sep '253.77Dec '25-0.87Apr '26-1.39Jul '260.82Oct '26

Free cash flow by quarter

$188.0MDec '24$234.0MMar '25$18.0MJun '25$162.0MSep '25$125.8MDec '25$-42.0MApr '26$153.0MJul '26$54.0MOct '26

Annual revenue

$2.4BFY20$2.8BFY21$3.0BFY22$3.0BFY23$3.0BFY24$3.2BFY25

Profitability & balance sheet

Gross margin49.5%
Operating margin5.8%
Net margin1.8%
Return on equity1.1%
Return on assets0.7%
Return on invested capital2.0%
Current ratio1.89
Liabilities / assets36.6%
Cash & investments$593.00M
Total debt$5.45B
Net cash (debt)-$4.85B
Free cash flow / sales5.2%

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Analytical & Materials Sciences$796.00M 45.0%
  • Advanced Diagnostics$575.00M 32.5%
  • Biosciences$396.00M 22.4%

SEC annual financial snapshot

Standard US-GAAP figures from 10-K filings in USD. Figures may reflect restatements. Checked 2026-11-22 11:51 UTC.

MetricUSDBasisPeriod endFiled / SEC source
Revenue$3.17BAnnual2025-12-312026-02-23
Net income$642.63MAnnual2025-12-312026-02-23
Operating cash flow$652.56MAnnual2025-12-312026-02-23
Total assets$5.08BPeriod end2025-12-312026-02-23
Total liabilities$2.52BPeriod end2025-12-312026-02-23
Stockholders’ equity$2.56BPeriod end2025-12-312026-02-23
Cash and cash equivalents$587.83MPeriod end2025-12-312026-02-23

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $1.77B $1.65B $1.27B $3.17B $932.29M
Total Operating Revenue $1.77B $1.65B $1.27B $3.17B $932.29M
Cost of Revenue $879.00M $911.00M $679.00M $1.29B $362.82M
Gross Profit $888.00M $734.00M $588.00M $1.88B $569.46M
Operating Expense $748.00M $771.00M $635.00M $1.07B $302.88M
Selling and Admin Expenses $398.00M $405.00M $387.00M $830.37M $244.37M
Research & Development $106.00M $122.00M $96.00M $195.71M $46.71M
Depreciation & Amortization & Depletion $244.00M $244.00M $152.00M $47.79M $11.79M
-Depreciation & Amortization $244.00M $244.00M $152.00M $47.79M $11.79M
Operating Profit $140.00M -$37.00M -$47.00M $802.59M $266.59M
Net Non-Operating Interest Income (Expense) -$53.00M -$55.00M -$42.00M -$50.77M -$8.77M
Non-Operating Interest Income $6.00M $5.00M $6.00M $18.78M $5.78M
Non-Operating Interest Expense $59.00M $60.00M $48.00M $69.55M $14.55M
Other Income (Expense) -$12.00M -$49.00M $1.00M $3.06M $6.06M
Special Income (Charges) -$12.00M -$49.00M – $0.00 $4.00M
-Less:Restructuring and Mergern & Acquisition $12.00M $49.00M – – –
Pretax Profit $74.00M -$141.00M -$88.00M $754.88M $263.88M
Tax -$7.00M -$5.00M -$16.00M $112.25M $39.25M
Net Profit $81.00M -$136.00M -$72.00M $642.63M $224.63M
Profit from Continuing Operations $81.00M -$136.00M -$72.00M $642.63M $224.63M
Net Income to Parent Company $81.00M -$136.00M -$72.00M $642.63M $225.63M
Net Income to Common Stockholders $81.00M -$136.00M -$72.00M $642.63M $225.63M
Basic EPS $0.83 -$1.39 -$0.87 $10.80 $3.78
Diluted EPS $0.82 -$1.39 -$0.87 $10.76 $3.77
Dividend Per Share $0.00 $0.00 $0.00 $0.00 $0.00
Other Non-Operating Income (Expenses) – – $1.00M $3.06M $2.06M

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $24.12B $24.75B $24.53B $5.08B $5.08B
Total Current Assets $4.13B $4.47B $4.06B $2.15B $2.15B
Cash and Cash Equivalents & Short-Term Investments $593.00M $539.00M $462.00M $587.83M $587.83M
-Cash and Cash Equivalents $593.00M $539.00M $462.00M $587.83M $587.83M
Receivables $1.46B $1.99B $1.75B $828.84M $828.84M
-Accounts Receivable $1.46B $1.99B $1.75B $828.84M $828.84M
Inventory $1.32B $1.38B $1.50B $572.37M $572.37M
Other Current Assets $744.00M $562.00M $353.00M $158.60M $158.60M
Total Non-Current Assets $19.99B $20.29B $20.47B $2.93B $2.93B
Net PPE $1.82B $1.86B $1.88B $722.81M $722.81M
-Gross PPE $1.82B $1.86B $1.88B $1.56B $1.56B
Goodwill and Other Intangible Assets $17.66B $17.94B $18.09B $1.90B $1.90B
-Goodwill $9.37B $9.42B $9.32B $1.34B $1.34B
-Other Intangible Assets $8.30B $8.52B $8.78B $558.18M $558.18M
Other Non-Current Assets $506.00M $489.00M $498.00M $307.84M $307.84M
Total Liabilities $8.82B $9.56B $9.24B $2.52B $2.52B
Total Current Liabilities $2.18B $2.40B $2.27B $1.24B $1.24B
Payables $402.00M $873.00M $649.00M $139.31M $139.31M
-Accounts Payable $377.00M $863.00M $602.00M $103.78M $103.78M
-Total Tax Payable $25.00M $10.00M $47.00M $35.53M $35.53M
Current Accrued Expenses $22.00M $21.00M $22.00M $12.26M $12.26M
Short-Term Debt and Capital Lease Obligation $702.00M $251.00M $413.00M $491.09M $491.09M
-Current Debt $650.00M $200.00M $360.00M $460.00M $460.00M
-Current Capital Lease Obligation $52.00M $51.00M $53.00M $31.09M $31.09M
Current Deferred Liabilities $463.00M $495.00M $520.00M $266.54M $266.54M
Other Current Liabilities $367.00M $545.00M $473.00M $230.65M $230.65M
Total Non-Current Liabilities $6.64B $7.16B $6.97B $1.28B $1.28B
Long Term Accounts Payable and Other Payables $22.00M $32.00M $28.00M $34.08M $34.08M
Long Term Debt and Capital Lease Obligation $4.80B $5.20B $5.16B $999.99M $999.99M
-Long Term Debt $4.48B $4.89B $4.86B $947.45M $947.45M
-Long Term Capital Lease Obligation $314.00M $317.00M $302.00M $52.55M $52.55M
Non-Current Deferred Liabilities $1.60B $1.71B $1.57B – –
Employee Benefits $83.00M $59.00M $57.00M $43.92M $43.92M
Other Non-Current Liabilities $140.00M $158.00M $156.00M $197.82M $197.82M
Total Equity $15.29B $15.20B $15.29B $2.56B $2.56B
Stockholders' Equity $15.29B $15.20B $15.29B $2.56B $2.56B
Capital Stock $2.00M $2.00M $2.00M $1.63M $1.63M
-Common Stock $2.00M $2.00M $2.00M $1.63M $1.63M
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $15.34B $15.31B $15.27B $2.42B $2.42B
Retained Earnings $10.30B $10.22B $10.36B $10.43B $10.43B
Less: Treasury Stock -$10.18B -$10.18B -$10.17B -$10.16B -$10.16B
Gains/Losses Not Affecting Retained Earnings -$182.00M -$166.00M -$168.00M -$125.45M -$125.45M
-Accumulated Depreciation – – – -$840.26M -$840.26M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $117.00M $201.00M -$3.00M $652.56M $164.56M
Net cash flow from continuing operations $117.00M $201.00M -$3.00M $652.56M $165.56M
Net Income from Continuing Operations $81.00M -$136.00M -$72.00M $642.63M $225.63M
Depreciation & Depletion & Amortization $300.00M $301.00M $207.00M $206.24M $53.24M
Deferred Tax -$109.00M $115.00M -$1.00M -$14.66M $2.34M
Other Non-Cash Items $80.00M $154.00M $99.00M -$2.40M -$3.40M
Change in Working Capital -$257.00M -$258.00M -$256.00M -$233.38M -$127.38M
-Change in Receivables $522.00M -$249.00M -$533.00M -$55.50M -$81.50M
-Change in Inventory -$17.00M -$35.00M -$33.00M -$65.93M $67,000.00
-Change in Payables and Accrued Expense -$453.00M $322.00M $235.00M -$89.01M $24.99M
-Change in Other Current Assets -$205.00M -$413.00M $76.00M -$11.56M -$42.56M
-Change in Other Current Liabilities -$71.00M $139.00M -$139.00M -$12.34M $4.66M
-Change In Other Working Capital -$33.00M -$22.00M $138.00M $957,000.00 -$33.04M
Net cash flow from investing -$113.00M $2.00M $95.00M -$152.25M -$42.25M
Net Cash Flow from Continuing Investing Activities -$114.00M $3.00M $95.00M -$152.25M -$42.25M
Net PPE Purchase and Sale -$63.00M -$48.00M -$39.00M -$112.75M -$38.75M
Net Business Purchase and Sale -$59.00M $0.00 $134.00M -$7.30M $28.71M
Net Investment Purchase and Sale $8.00M – – $0.00 $0.00
Net Other Investing Changes $9.00M – – -$32.21M –
Financing Cash Flow $58.00M -$124.00M -$213.00M -$237.21M $3.80M
Net Cash Flow from Continuing Financing Activities $58.00M -$124.00M -$213.00M -$237.21M $3.80M
Net Issuance Payments Of Debt $45.00M -$128.00M -$170.00M -$220.00M $0.00
Net Common Stock Issuance -$1.00M -$2.00M -$12.00M -$14.67M $333,000.00
Proceeds from Stock Option Exercised $11.00M $12.00M $3.00M $20.79M $4.79M
Net Other Financing Charges $3.00M -$6.00M -$34.00M -$23.33M -$1.33M
Ending Cash Balance $593.00M $539.00M $462.00M $587.83M $587.83M
Net Change in Cash $62.00M $79.00M -$121.00M $263.10M $125.10M
Beginning Cash Balance $539.00M $462.00M $588.00M $325.36M $459.00M
Effect of Exchange Rate Changes -$8.00M -$2.00M -$5.00M -$621,000.00 $3.38M
Free Cash Flow $54.00M $153.00M -$42.00M $539.81M $125.81M

Discussion

No comments yet — be the first to weigh in on WAT.

Sign in to join the discussion.

Scroll to Top